02

Iraq Country Profile

Market landscape & healthcare environment.

Key facts

Iraq at a glance

~47M Total population
0 Sq km area
70–72 Years life expectancy
IQD Monetary unit
Full name Republic of Iraq
Capital Baghdad
Main exports Crude oil

Source: World Bank, UN Data, 2024 estimates

Map of Iraq — Kurdistan Region highlighted IRAQ KURDISTAN Baghdad Erbil
Map of Iraq — Kurdistan Region highlighted
Population

Demographics

A young, fast-growing population driving sustained healthcare demand.

Indicator Value
Age structure (0–14 years)~ 35%
Age structure (15–64 years)~ 60–62%
Age structure (65+ years)~ 3–5%
Crude birth rate~ 22–25 births / 1,000 population
Crude death rate~ 4.5–5.5 deaths / 1,000 population
Total fertility rate~ 3.0–3.4 children born / woman
Population growth rate~ 2.0–2.3%
~2.3% Annual growth
  • Age structure (0–14 years) — 35%
  • Age structure (15–64 years) — 61%
  • Age structure (65+ years) — 4%
Disease burden

Top 10 diseases causing morbidity

1Gastroenteritis
6Abortion
2Bronchitis
7Measles
3Pneumonia
8Hernia
4Cardiovascular disease
9Respiratory distress syndrome
5Urinary system disorders
10Diabetes mellitus

Source: MOH / Directorate of Planning & Human Resource Development, 2016.

Mortality

Major causes of mortality

According to the Ministry of Health (MOH) – Directorate of Planning & Human Resource Development (2016), the leading causes of mortality in Iraq are predominantly non-communicable and chronic diseases, along with infectious and external causes.

  • Cardiovascular diseases (including heart failure and ischemic heart disease)
  • Cerebrovascular diseases (stroke)
  • External causes of death (injuries and accidents)
  • Chronic kidney (renal) failure
  • Infectious diseases such as septicemia
  • Respiratory diseases
  • Diabetes mellitus
  • Malignant tumors, particularly gastrointestinal cancers
  • Age-related conditions

Source: MOH / Directorate of Planning & Human Resource Development, 2016.

Opportunity

What this means for our partners

A population of roughly 47 million growing at over 2% a year, with a chronic-disease burden concentrated in cardiovascular, respiratory, renal and metabolic care, creates sustained demand across the therapeutic areas we distribute.

Become a partner